{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:41:07Z","timestamp":1757313667685},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI SPORE in Soft Tissue Sarcoma","award":["P50 CA140146"],"award-info":[{"award-number":["P50 CA140146"]}]},{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1245\/s10434-022-12053-7","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T15:08:42Z","timestamp":1656601722000},"page":"7115-7121","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Feasibility of Preoperative Dose-Painting Intensity Modulated Radiation Therapy (IMRT) for Borderline-Resectable Primary Retroperitoneal Sarcoma"],"prefix":"10.1245","volume":"29","author":[{"given":"Minsi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimee","family":"Crago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam S.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaled","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"issue":"4","key":"12053_CR1","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ejca.2013.11.021","volume":"50","author":"A Gronchi","year":"2014","unstructured":"Gronchi A, De Paoli A, Dani C, et al. Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group. Eur J Cancer. 2014;50(4):784\u201392.","journal-title":"Eur J Cancer"},{"issue":"3","key":"12053_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ijrobp.2011.04.009","volume":"82","author":"NN Paryani","year":"2012","unstructured":"Paryani NN, Zlotecki RA, Swanson EL, et al. Multimodality local therapy for retroperitoneal sarcoma. Int J Radiat Oncol Biol Phys. 2012;82(3):1128\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"12053_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1245\/ASO.2006.05.035","volume":"13","author":"TM Pawlik","year":"2006","unstructured":"Pawlik TM, Pisters PW, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006;13(4):508\u201317.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"12053_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/cncr.22005","volume":"107","author":"CW Tzeng","year":"2006","unstructured":"Tzeng CW, Fiveash JB, Popple RA, et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer. 2006;107(2):371\u20139.","journal-title":"Cancer"},{"issue":"1","key":"12053_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/SLA.0000000000001063","volume":"262","author":"KJ Kelly","year":"2015","unstructured":"Kelly KJ, Yoon SS, Kuk D, et al. Comparison of perioperative radiation therapy and surgery versus surgery alone in 204 patients with primary retroperitoneal sarcoma: a retrospective 2-institution study. Ann Surg. 2015;262(1):156\u201362.","journal-title":"Ann Surg"},{"issue":"10","key":"12053_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S1470-2045(20)30446-0","volume":"21","author":"S Bonvalot","year":"2020","unstructured":"Bonvalot S, Gronchi A, Le Pechoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1366\u201377.","journal-title":"Lancet Oncol"},{"issue":"1","key":"12053_CR7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S1470-2045(20)30632-X","volume":"22","author":"T DeLaney","year":"2021","unstructured":"DeLaney T, Mullen JT, Wang D, Goldberg SI, Kirsch DG. Preoperative radiotherapy for retroperitoneal sarcoma. Lancet Oncol. 2021;22(1):e1.","journal-title":"Lancet Oncol"},{"issue":"15_suppl","key":"12053_CR8","doi-asserted-by":"publisher","first-page":"11566","DOI":"10.1200\/JCO.2021.39.15_suppl.11566","volume":"39","author":"RLM Haas","year":"2021","unstructured":"Haas RLM, Stelmes J-J, Zaffaroni F, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: results from the 62092\u201322092 STRASS trial. J Clin Oncol. 2021;39(15_suppl):11566.","journal-title":"J Clin Oncol"},{"issue":"13","key":"12053_CR9","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1200\/JCO.2012.44.3747","volume":"31","author":"A Gronchi","year":"2013","unstructured":"Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31(13):1649\u201355.","journal-title":"J Clin Oncol"},{"issue":"5","key":"12053_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/jso.26586","volume":"124","author":"MH Squires","year":"2021","unstructured":"Squires MH, Ethun CG, Donahue EE, et al. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma. J Surg Oncol. 2021;124(5):829\u201337.","journal-title":"J Surg Oncol"},{"issue":"1","key":"12053_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","volume":"27","author":"S Bonvalot","year":"2009","unstructured":"Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27(1):31\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"12053_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/jso.24256","volume":"114","author":"E Abdelfatah","year":"2016","unstructured":"Abdelfatah E, Guzzetta AA, Nagarajan N, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: a 15 year single-institution evaluation of prognostic features. J Surg Oncol. 2016;114(1):56\u201364.","journal-title":"J Surg Oncol"},{"issue":"3","key":"12053_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","volume":"228","author":"JJ Lewis","year":"1998","unstructured":"Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355\u201365.","journal-title":"Ann Surg"},{"issue":"15_suppl","key":"12053_CR14","doi-asserted-by":"publisher","first-page":"11550","DOI":"10.1200\/JCO.2021.39.15_suppl.11550","volume":"39","author":"TF DeLaney","year":"2021","unstructured":"DeLaney TF, Mullen JT, Chen Y-L, et al. Preliminary results of phase 2 trial of preoperative image guided intensity modulated proton radiation therapy (IMPT) with simultaneously integrated boost (SIB) to the high-risk margin for retroperitoneal sarcomas (RPS). J Clin Oncol. 2021;39(15_suppl):11550.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12053-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12053-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T15:20:17Z","timestamp":1663773617000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12053-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["12053"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12053-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,30]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Aimee Crago, Advisory board\u2014Springworks Therapeutics","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}